Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years
Yasmin Jayasinghe, Cheryl Rangiah, Alexandra Gorelik, Gina Ogilvie, John D Wark, Stefanie Hartley, Suzanne M Garland
Journal of Clinical Virology | ELSEVIER SCIENCE BV | Published : 2016
None declared. YJ has received scholarship funding from the Cancer Council Victoria, Royal Australian and New Zealand College of Obstetricians and Gynaecologists, and Royal Australasian Chapter of Sexual Health Medicine (Novartis Scholarship) and grant funding from the Victorian Cancer Agency and Victorian Comprehensive Cancer Network for unrelated projects. SG has received grant support from CSL Bio, Merck and GlaxoSmithKline to conduct HPV vaccine studies (VIVIANNE) trial. SG is a member of the Merck Global Advisory Board as well as the Merck Scientific Advisory Committee for HPV (unpaid position).